Gregory Alan Jones
Known title: VP of Food and Health SciencesCIK: 0002067498
Associated companies
Transaction History
| HWKN | ▲ Buy | Grant | 1,970 | $0 | 5/13/2026 | View on chart |
| HWKN | ▲ Buy | Grant | 3,411 | $0 | 5/14/2025 | View on chart |
| HWKN | ▲ Buy | Grant | 1,970 | $0 | 5/13/2026 | View on chart |
| HWKN | ▲ Buy | Grant | 3,411 | $0 | 5/14/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Hawkins Inc. to Report Q2 Fiscal 2027 Results on Oct 26
Hawkins Inc. has scheduled its second-quarter fiscal 2027 earnings release for October 26, 2026. This upcoming report is the primary catalyst for the stock in the near term, as investors await updated financial data. While a related article mentioned RPM International's earnings, that news pertains to a different company and does not directly impact Hawkins' immediate outlook.
Hawkins Inc. to Report Q2 Fiscal 2027 Results on Oct 26. Hawkins Inc. has scheduled its second-quarter fiscal 2027 earnings release for October 26, 2026. This upcoming report is the primary catalyst for the stock in the near term, as investors await updated financial data. While a related article mentioned RPM International's earnings, that news pertains to a different company and does not directly impact Hawkins' immediate outlook.